Pharma 5 Markets the First Moroccan Medicine Based on Cannabis

T

he laboratory Pharma 5 presented on Thursday, November 12 in Casablanca its first medicine based on cannabidiol, an antiepileptic on sale in Morocco since November 9 under the name of Cannabidiol Pharma 5.

This oral solution is intended for the treatment of certain severe forms of drug-resistant epilepsy.

Its active substance, cannabidiol, is purified to more than 98% by the laboratory, which thus claims the first pharmaceutical active substance entirely Moroccan derived from cannabis.

The regulated cultivation of the plant in the Rif, first link of the chain, provides a living to 70 local families now integrated into the formal sector. Law 13-21 has framed since 2021 the medical and industrial uses of cannabis in Morocco.

Five years of research and development will have been necessary, for an investment of 200 million dirhams.

Photo: GuHKS, CC BY-SA 4.0.

References:

Les Éco - Cannabis thérapeutique: Pharma 5 concrétise cinq ans d’investissements

Aujourd’hui le Maroc - Souveraineté sanitaire nationale: Pharma 5 lance le premier médicament antiépileptique 100% marocain à base de cannabis thérapeutique

La Nouvelle Tribune - Pharma 5: 200 MDH pour le premier médicament marocain à base de cannabis rifain

Médias24 - Épilepsie: Pharma 5 annonce la disponibilité de son premier médicament à base de cannabis au Maroc